Gude, Kerstin

No ORCID on file · 4 papers in corpus · active 2024

Study types

  • article 2
  • other 2

Condition tags

  • endometriosis 4
article 2024
Additional file 1 of Efficacy and safety of eliapixant in endometriosis-associated pelvic pain: the randomized, placebo-controlled phase 2b SCHUMANN study
·doi:10.6084/m9.figshare.26061474.v1

Supplementary Material 1

article 2024
Additional file 1 of Efficacy and safety of eliapixant in endometriosis-associated pelvic pain: the randomized, placebo-controlled phase 2b SCHUMANN study
·doi:10.6084/m9.figshare.26061474

Supplementary Material 1

other 2024
Efficacy and safety of eliapixant in endometriosis-associated pelvic pain: the randomized, placebo-controlled phase 2b SCHUMANN study
·doi:10.6084/m9.figshare.c.7292328

Abstract Background The SCHUMANN study evaluated the efficacy and safety of the selective P2 × 3 antagonist eliapixant in patients with endometriosis-associated pelvic pain (EAPP). Methods SCHUMANN was a randomized, placebo- and active comp…

other 2024
Efficacy and safety of eliapixant in endometriosis-associated pelvic pain: the randomized, placebo-controlled phase 2b SCHUMANN study
·doi:10.6084/m9.figshare.c.7292328.v1

Abstract Background The SCHUMANN study evaluated the efficacy and safety of the selective P2 × 3 antagonist eliapixant in patients with endometriosis-associated pelvic pain (EAPP). Methods SCHUMANN was a randomized, placebo- and active comp…